Immunodiagnostic Systems Holdings plc (“IDS” or the “Company” or the “Group”), a leading producer of diagnostic testing kits for the clinical and research markets, announces its interim results for the six month period to 30 September 2009. IDS operates in the in-vitro diagnostics (“IVD”) market. The Company designs, manufactures and sells immunoassay kits which are […]
